<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Trompet E</submitter><funding>Fonds Wetenschappelijk Onderzoek</funding><pagination>985</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8227558</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(6)</volume><pubmed_abstract>Drug resistance studies on human γ-herpesviruses are hampered by the absence of an in vitro system that allows efficient lytic viral replication. Therefore, we employed murine γ-herpesvirus-68 (MHV-68) that efficiently replicates in vitro as a model to study the antiviral resistance of γ-herpesviruses. In this study, we investigated the mechanism of resistance to nucleoside (ganciclovir (GCV)), nucleotide (cidofovir (CDV), HPMP-5azaC, HPMPO-DAPy) and pyrophosphate (foscarnet (PFA)) analogues and the impact of these drug resistance mutations on viral fitness. Viral fitness was determined by dual infection competition assays, where MHV-68 drug-resistant viral clones competed with the wild-type virus in the absence and presence of antivirals. Using next-generation sequencing, the composition </pubmed_abstract><journal>Viruses</journal><pubmed_title>An MHV-68 Mutator Phenotype Mutant Virus, Confirmed by CRISPR/Cas9-Mediated Gene Editing of the Viral DNA Polymerase Gene, Shows Reduced Viral Fitness.</pubmed_title><pmcid>PMC8227558</pmcid><funding_grant_id>1S04516N</funding_grant_id><pubmed_authors>Trompet E</pubmed_authors><pubmed_authors>Andrei G</pubmed_authors><pubmed_authors>Topalis D</pubmed_authors><pubmed_authors>Temblador A</pubmed_authors><pubmed_authors>Snoeck R</pubmed_authors><pubmed_authors>Gillemot S</pubmed_authors></additional><is_claimable>false</is_claimable><name>An MHV-68 Mutator Phenotype Mutant Virus, Confirmed by CRISPR/Cas9-Mediated Gene Editing of the Viral DNA Polymerase Gene, Shows Reduced Viral Fitness.</name><description>Drug resistance studies on human γ-herpesviruses are hampered by the absence of an in vitro system that allows efficient lytic viral replication. Therefore, we employed murine γ-herpesvirus-68 (MHV-68) that efficiently replicates in vitro as a model to study the antiviral resistance of γ-herpesviruses. In this study, we investigated the mechanism of resistance to nucleoside (ganciclovir (GCV)), nucleotide (cidofovir (CDV), HPMP-5azaC, HPMPO-DAPy) and pyrophosphate (foscarnet (PFA)) analogues and the impact of these drug resistance mutations on viral fitness. Viral fitness was determined by dual infection competition assays, where MHV-68 drug-resistant viral clones competed with the wild-type virus in the absence and presence of antivirals. Using next-generation sequencing, the composition </description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 May</publication><modification>2026-04-08T09:10:49.394Z</modification><creation>2022-02-10T19:51:35.362Z</creation></dates><accession>S-EPMC8227558</accession><cross_references><pubmed>34073189</pubmed><doi>10.3390/v13060985</doi></cross_references></HashMap>